Klee Justin B. bought AMLX
January 15, 2026 · Form 4 insider transaction
Klee Justin B. bought 197,153 shares of Amylyx Pharmaceuticals, Inc. at $7.57 per share, a transaction worth $1.49M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
197,153
Price
$7.57
Total value
$1.49M
InsiderKlee Justin B.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 15, 2026
Filing dateJanuary 20, 2026
Shares owned after3,514,739
OwnershipDirect
10b5-1 planNo
AmendedNo